Orchestra BioMed Holdings, Inc. Increase (Decrease) in Accounts Receivable
Orchestra BioMed Holdings, Inc. (OBIO) reported Increase (Decrease) in Accounts Receivable of -$44.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$33.00K.
- Orchestra BioMed Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$11.00K.
- Orchestra BioMed Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $43.00K.
- Orchestra BioMed Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$31.00K, a 188.57% decline year-over-year.
- Orchestra BioMed Holdings, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $3.00K.
- Orchestra BioMed Holdings, Inc. increase (decrease) in accounts receivable for fiscal 2024 was -$22.00K, a 833.33% decline from fiscal 2023.
- Orchestra BioMed Holdings, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $3.00K.
- Orchestra BioMed Holdings, Inc. increase (decrease) in accounts receivable for fiscal 2022 was -$25.00K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$44.00K 10-Q · filed 2026-08-10 | -$1.00K derived: sum of 3 quarters · filed 2026-08-10 | -$32.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$11.00K 10-Q · filed 2026-05-12 | $32.00K derived: sum of 2 quarters · filed 2026-05-12 | $1.00K derived: sum of 3 quarters · filed 2026-05-12 | -$5.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $12.00K derived: sum of 2 quarters · filed 2026-03-12 | $6.00K derived: sum of 3 quarters · filed 2026-08-10 | $3.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | -$31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$37.00K derived: sum of 2 quarters · filed 2026-08-10 | -$40.00K 10-Q · filed 2025-11-10 | -$78.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$9.00K 10-Q · filed 2026-08-10 | -$47.00K derived: sum of 3 quarters · filed 2026-08-10 | -$12.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$3.00K 10-Q · filed 2026-05-12 | -$41.00K derived: sum of 2 quarters · filed 2026-05-12 | -$6.00K derived: sum of 3 quarters · filed 2026-05-12 | $7.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$3.00K derived: sum of 2 quarters · filed 2026-03-12 | $10.00K derived: sum of 3 quarters · filed 2026-03-12 | -$22.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $48.00K derived: sum of 2 quarters · filed 2025-11-10 | $16.00K 10-Q · filed 2025-11-10 | $29.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$19.00K 10-Q · filed 2025-08-12 | -$6.00K derived: sum of 3 quarters · filed 2025-08-12 | -$91.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$32.00K 10-Q · filed 2025-05-12 | -$19.00K derived: sum of 2 quarters · filed 2025-05-12 | -$104.00K derived: sum of 3 quarters · filed 2025-05-12 | -$9.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$72.00K derived: sum of 2 quarters · filed 2025-03-31 | $23.00K derived: sum of 3 quarters · filed 2025-03-31 | $3.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $10.00K derived: sum of 2 quarters · filed 2024-11-12 | -$10.00K 10-Q · filed 2024-11-12 | -$10.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $95.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $75.00K 10-Q · filed 2024-08-12 | $75.00K derived: sum of 3 quarters · filed 2024-08-12 | $91.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$20.00K 10-Q · filed 2024-05-13 | -$20.00K derived: sum of 2 quarters · filed 2024-05-13 | -$4.00K derived: sum of 3 quarters · filed 2024-05-13 | -$3.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $16.00K derived: sum of 2 quarters · filed 2024-03-27 | $17.00K derived: sum of 3 quarters · filed 2024-03-27 | -$25.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $17.00K derived: sum of 2 quarters · filed 2023-11-13 | -$25.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$41.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | -$42.00K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |